These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33959660)

  • 21. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).
    Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI;
    Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term Outcome of Angioplasty Using a Wingspan Stent, Post-Stent Balloon Dilation and Aggressive Restenosis Management for Intracranial Arterial Stenosis.
    Park SC; Cho SH; Kim MK; Kim JE; Jang WY; Lee MK; Jo KD; You SH
    Clin Neuroradiol; 2020 Mar; 30(1):159-169. PubMed ID: 31123775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRIS.
    Miao Z; Song L; Liebeskind DS; Liu L; Ma N; Wang Y; Mo D; Gao F; Zhao X; Dong K; Zhang D; Gao P
    J Neurointerv Surg; 2015 May; 7(5):331-5. PubMed ID: 24759694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balloon-mounting stent versus balloon angioplasty for intracranial arterial stenosis: A systematic review and meta-analysis.
    Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Liu J; Jabbour P; Hasan D; Zomorodi A
    J Stroke Cerebrovasc Dis; 2024 May; 33(5):107631. PubMed ID: 38331010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Outcome of Enterprise Stenting for Symptomatic ICAS in a High-Volume Stroke Center.
    Cui R; Yan L; Kang K; Yang M; Yu Y; Mo D; Gao F; Wang Y; Lou X; Miao Z; Ma N
    Front Neurol; 2021; 12():672662. PubMed ID: 34220681
    [No Abstract]   [Full Text] [Related]  

  • 27. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
    Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
    Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of rescue angioplasty and/or stenting for acute large artery occlusion with underlying intracranial atherosclerosis: A systematic review and meta-analysis.
    Zhang P; Xing Y; Li H; Yao Q; Shen J; Liu Y; Wei Y; Guo Y
    Clin Neurol Neurosurg; 2021 Apr; 203():106538. PubMed ID: 33607582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.
    Kim JK; Ahn JY; Lee BH; Chung YS; Chung SS; Kim OJ; Kim WC; Joo JY
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):847-51. PubMed ID: 15145998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases.
    Wolfe TJ; Fitzsimmons BF; Hussain SI; Lynch JR; Zaidat OO
    J Neurointerv Surg; 2009 Jul; 1(1):40-3. PubMed ID: 21994104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endovascular treatment of symptomatic intracranial atherosclerotic stenosis with low profile visualized intraluminal support stent.
    Tang H; Lu Z; Zeng Z; Zuo Q; Li Q; Xu F; Huang Q; Liu J
    J Clin Neurosci; 2021 Aug; 90():256-261. PubMed ID: 34275559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and Risk Factors of In-Stent Restenosis for Symptomatic Intracranial Atherosclerotic Stenosis: A Systematic Review and Meta-Analysis.
    Peng G; Zhang Y; Miao Z
    AJNR Am J Neuroradiol; 2020 Aug; 41(8):1447-1452. PubMed ID: 32732271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.
    Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of balloon-mounted stent in the treatment of symptomatic intracranial atherosclerotic disease: a multicenter experience.
    Mohammaden MH; Nogueira RG; Tekle W; Ortega-Gutierrez S; Farooqui M; Zevallos CB; Hanel RA; Cortez GM; Aghaebrahim A; Starke RM; Aref H; Elbassiouny A; Gamea A; Alaraj A; Sadeh M; Grigoryan M; Kuybu O; Haussen DC; Sheth SA; Maud A; Cordina SM; Tanweer O; Kan P; Burkhardt JK; Grandhi R; Siddiq F; Hassan AE
    J Neurointerv Surg; 2022 Aug; 14(8):756-761. PubMed ID: 34349013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent.
    Vajda Z; Schmid E; Güthe T; Klötzsch C; Lindner A; Niehaus L; Sperber W; Peters J; Arnold G; Bäzner H; Henkes H
    Neurosurgery; 2012 Jan; 70(1):91-101; discussion 101. PubMed ID: 21778921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It.
    Mekonnen EA; Tekle WG; Desai SK; Hassan AE
    Interv Neuroradiol; 2023 Aug; 29(4):459-465. PubMed ID: 35331035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease: A systematic review and meta-analysis.
    Ye G; Yin X; Yang X; Wang J; Qi P; Lu J; Wang L; Wang D
    J Clin Neurosci; 2019 Jan; 59():112-118. PubMed ID: 30401573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical and angiographic outcome from angioplasty and stenting for intracranial stenosis.
    Park SK; Suh SH; Jang KS; Jang DK; Jo DY; Shin YS
    Acta Neurochir (Wien); 2022 Jun; 164(6):1627-1634. PubMed ID: 35001232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience.
    Krajíčková D; Krajina A; Lojík M; Mulačová M; Vališ M
    Vasa; 2013 Jul; 42(4):264-74. PubMed ID: 23823858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.